Newly-developed blood test could predict severity of COVID-19 infections


Scientists have developed a blood test that could help doctors predict whether a COVID-19 patient may need intensive care shortly after they develop symptoms, reports The Guardian. It may even predict how likely they are to survive the infection.
The team of scientists initially identified 27 proteins in the blood of COVID-19 patients that were present at different levels depending on symptom severity, and since then they've followed 160 patients who had their blood tested to determine if their protein signature could predict the progression of their illness. If the hypothesis is validated in hospital settings in the coming weeks, the test could be crucial in helping doctors choose whether to provide life-saving treatment in the earlier stages of infection. The coronavirus has proven particularly challenging because some patients will sometimes report feeling relatively well and then rapidly deteriorate, so the blood test could potentially help catch those cases, The Guardian notes.
"It turns out that such patients have an early inflammatory response to the infection, which we can measure in the blood and use to say, 'OK, 40 days down the line, this is your likely outcome'," said Ralser, a professor of biochemistry at the Francis Crick Institute in London and Charité University Medicine in Berlin. "Every day counts with severe COVID, and those people who need intensive care need to get it as soon as possible because this greatly increases their chances of survival."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The test, like many COVID-19-related developments, wouldn't be a singular tool, but instead could provide important data for health care workers who are faced with difficult decisions. Read more at The Guardian.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
AI chatbots are leading some to psychosis
The explainer The technology may be fueling delusions
-
'Self-segregation by political affiliation is spreading'
Instant Opinion Opinion, comment and editorials of the day
-
7 places across the country to experience the best of summer drinking
The Week Recommends Stops include a Basque-inspired spot and a bar where the menu overhauls twice a year
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments